Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
4
×
national blog main
san francisco blog main
4
×
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
europe blog main
europe top stories
abaloparatide
amgen
amy heimberer
arena pharmaceuticals
barrow neurological institute
ben and catherine ivy foundation
blueprint medicines
brain cancer
What
drug
4
×
medicine
4
×
cancer
fda
marketing
alzheimer's
amgen
amgen’s
approval
approved
bad
brain
carries
case
deeper
developed
disease
dna
doses
eisai
europe
european
failed
fight
fingerprint
flags
fortune
genetic
goes
going
heart
help
higher
incidence
lorcaserin
loss
market
matter
modern
nd
Language
unset
Current search:
medicine
×
drug
×
national
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues